Cost of Adverse Drug Reactions (ADR) with Protease Inhibitors in the Treatment of Hepatitis C in the Health System of Extremadura (SES)

Abstract

A683suggest that PIM is a cost-effective treatment strategy compared to OTT for HIV-1 infected patients who have achieved sustained virological suppression.